Clinical Trials Directory

Trials / Completed

CompletedNCT03834896

Madrid - Tolerance and Acceptability Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Aymes International Limited · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Tolerance and Acceptability of a gum based thickener.

Detailed description

To evaluate the tolerance and acceptability of AYMES MADRID, in patients that may require modified consistency fluids. Measuring GI tolerance, compliance, convenience and preference. To obtain data to support an ACBS submissions for AYMES MADRID (to allow for prescription in the community at NHS expense).

Conditions

Interventions

TypeNameDescription
OTHERAYMES MADRIDAYMES MADRID is a gum-based commercial thickener, that can be utilised to modify fluid consistencies to Stage 1, 2 or 3 (as per the National Descriptors for Texture Modification) to enhance the safety of fluids in those with dysphagia.

Timeline

Start date
2017-11-01
Primary completion
2018-01-01
Completion
2018-01-01
First posted
2019-02-08
Last updated
2019-02-08

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03834896. Inclusion in this directory is not an endorsement.